These novel data pointed towards the diagnostic ability of TM6SF2-polymorphism to identify individuals at higher risk for developing NAFLD, cirrhosis, and HCC, as well as alcohol-dependent liver disease [73]. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.